ASAS consensus definition of early axial spondyloarthritis

Objectives To develop a consensual definition for the term ‘early axial spondyloarthritis—axSpA’—and ‘early peripheral spondyloarthritis—pSpA’. Methods The ASAS (Assessment of SpondyloArthritis international Society-Spondyloarthritis EARly definition) steering committee convened an international working group (WG). Five consecutive steps were followed: (1) systematic literature review (SLR); (2) discussion of SLR results within the WG and ASAS community; (3) a three-round Delphi survey inviting all ASAS members to select the items that should be considered for the definition; (4) presentation of Delphi results to the WG and ASAS community and (5) ASAS voting and endorsement (2023 annual meeting). Results Following the SLR, consensus was to proceed with an expert-based definition for early axSpA (81% in favour) but not for pSpA (54% against). Importantly, early axSpA should be based on symptom duration taking solely axial symptoms into account. 151–164 ASAS members participated in the Delphi surveys. Consensus was achieved for considering the following items within early axSpA definition: duration of symptoms ≤2 years; axial symptoms defined as cervical/thoracic/back/buttock pain or morning stiffness; regardless of the presence/absence of radiographic damage. The WG agreed that in patients with a diagnosis of axSpA ‘early axSpA’ should be defined as a duration of ≤2 years of axial symptoms. Axial symptoms should include spinal/buttock pain or morning stiffness and should be considered by a rheumatologist as related to axSpA. The ASAS community endorsed this proposal (88% in favour). Conclusions Early axSpA has newly been defined, based on expert consensus. This ASAS definition should be adopted in research studies addressing early axSpA.

[1]  R. Landewé,et al.  ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update , 2022, Annals of the Rheumatic Diseases.

[2]  R. Landewé,et al.  Treating spondyloarthritis early: does it matter? Results from a systematic literature review. , 2022, Rheumatology.

[3]  R. Landewé,et al.  How is early spondyloarthritis defined in the literature? Results from a systematic review. , 2022, Seminars in arthritis and rheumatism.

[4]  D. M. van der Heijde,et al.  Axial spondyloarthritis , 2021, Annals of the Rheumatic Diseases.

[5]  J. Sieper,et al.  Twenty years of clinical trials in axial spondyloarthritis: what can we learn for the future? , 2021, Current opinion in rheumatology.

[6]  C. Bundy,et al.  Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis , 2021, Rheumatology.

[7]  M. Østergaard,et al.  Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine , 2020, Annals of the Rheumatic Diseases.

[8]  D. M. van der Heijde,et al.  Two different invitation approaches for consecutive rounds of a Delphi survey led to comparable final outcome. , 2020, Journal of clinical epidemiology.

[9]  M. Dougados,et al.  Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis , 2019, Annals of the rheumatic diseases.

[10]  A. Zink,et al.  Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. , 2019, Rheumatology.

[11]  M. Dougados,et al.  Measuring spinal mobility in early axial spondyloarthritis: does it matter? , 2019, Rheumatology.

[12]  M. Dougados,et al.  Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019 , 2019, Annals of the rheumatic diseases.

[13]  K. Raza,et al.  Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives , 2019, RMD Open.

[14]  D. M. van der Heijde,et al.  Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis , 2018, The Journal of Rheumatology.

[15]  A. Bennett,et al.  Short-term Repeat Magnetic Resonance Imaging Scans in Suspected Early Axial Spondyloarthritis Are Clinically Relevant Only in HLA-B27–positive Male Subjects , 2017, The Journal of Rheumatology.

[16]  M. Dougados,et al.  Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study , 2017, Arthritis care & research.

[17]  R. Landewé,et al.  Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis , 2017, RMD Open.

[18]  M. Dougados,et al.  2016 update of the EULAR recommendations for the management of early arthritis , 2016, Annals of the rheumatic diseases.

[19]  J. Braun,et al.  High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort , 2016, Annals of the rheumatic diseases.

[20]  E. Naredo,et al.  EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice , 2015, Annals of the rheumatic diseases.

[21]  V. Mazurov,et al.  Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2 , 2013, Annals of the rheumatic diseases.

[22]  D. M. van der Heijde,et al.  ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort , 2012, Annals of the rheumatic diseases.

[23]  Andreas Krause,et al.  Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial , 2011, Annals of the rheumatic diseases.

[24]  M. Dougados,et al.  The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general , 2010, Annals of the rheumatic diseases.

[25]  M. Dougados,et al.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection , 2009, Annals of the rheumatic diseases.

[26]  M. Soucek,et al.  AXIAL SPONDYLOARTHRITIS , 2023 .